19 results
425
SLXN
Biomotion Sciences Ordinary Shares
25 Jul 24
Business combination disclosure
4:05pm
run - in Phase 2 expanded Phase 3 21 World - Renowned Expert Scientific Advisory Board Eileen M. O'Reilly, MD Memorial Sloan Kettering, NY, NY
425
MACA
Moringa Acquisition Corp
25 Jul 24
Business combination disclosure
4:05pm
World - Renowned Expert Scientific Advisory Board Eileen M. O'Reilly, MD Memorial Sloan Kettering, NY, NY Winthrop Rockefeller Endowed Chair
DEFM14A
MACA
Moringa Acquisition Corp
17 Jul 24
Proxy related to merger
9:13am
. Brachfeld qualifies as an “audit committee financial expert” as defined in applicable SEC rules and has accounting or related financial management
PRE 14A
7b5nql62use17 2h2l4
15 Dec 22
Preliminary proxy
5:18pm
10-K
5wvy3ca4k0jowkrfgsf
31 Mar 21
Annual report
5:15pm
8-K
EX-10.8
wy04we4tl0yux
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.12
g5nein52 0wu3d5g
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.9
1nvvaxdo1
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.11
zc559ufcl1t0l1
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.10
smojrty6vs1p 7vq
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.6
l9h7o8f
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.7
vc3rbc4rjlpz8
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
424B4
c1zmo anelxkwrr1vt
17 Feb 21
Prospectus supplement with pricing info
11:53am
S-1
EX-10.7
ppm6 9s852aa
1 Feb 21
IPO registration
4:12pm
S-1
djbn2p qjgo
1 Feb 21
IPO registration
4:12pm
DRS
886g rv2p6l
22 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next